NeOnc Noses Into Novel Brain Cancer Treatment
Publication Date: July 25, 2024 Published By: Pharma Insider Article Link: https://www.mediapost.com/publications/article/397827/neonc-noses-into-novel-brain-cancer-treatment.html Treatment for brain cancer patients typically consists of surgery, radiation, and an oral drug called Temozolomide, developed by Merck and now generic. The most serious cases, however, still have less than a three-month survival rate, Dr. Thomas Chen, director of surgical neuro-oncology at […]




